Chronic Kidney Disease

Contributor: The Wrong Way to Design a Medicare Mandatory Demonstration

November 27th 2020, 1:00pm


Jackson Williams is vice president, public policy at Dialysis Patient Citizens. Previously he worked at the Centers for Medicare and Medicaid Services (CMS); was a health services researcher in the AARP Public Policy Institute; and a lobbyist on health policy issues for 3 nonprofit associations. His more than 2 decades of experience monitoring, studying, and overseeing federal demonstration projects include time as a project officer at CMMI and serving as the consumer representative on a Medicare pilot site’s governing body.

Dr George Bakris Discusses Next Steps for Finerenone

November 27th 2020, 12:15pm


If results from FIGARO-DKD are as positive as those of FIDELIO-DKD, the field will work aggressively to get the message out, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.

Dr George Bakris Speaks About Increasing Minority Representation in CKD Trials

November 21st 2020, 3:45pm


In the FIDELIO-DKD trial researchers purposely recruited centers that had very large African American databases, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.

Even in Advanced CKD, Canaglifozin Slows Rate of Kidney Decline, Study Says

November 19th 2020, 10:00pm


A new analysis of CREDENCE data showed that the sodium-glucose cotransporter 2 (SGLT2) inhibitor worked in advanced disease and without causing acute kidney injury.

Dr Rajiv Agarwal on the Future of Finerenone

November 13th 2020, 12:45pm


The FIDELIO-DKD program is perhaps just the beginning of seeing how finerenone can be used, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.

Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease

November 11th 2020, 2:00pm


Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.

The Kidney Community Advances Innovative Solutions and Improves Patient Care—Even During a National Pandemic Crisis

November 5th 2020, 2:00pm


Authors from the American Society of Nephrology and Kidney Care Partners discuss the response of the kidney care community to the COVID-19 pandemic.

Dr Joshua Rein Discusses the Next Steps of Cannabis Treatment for Kidney Disease

October 31st 2020, 1:00pm


The federal illegality and Schedule I listing of cannabis significantly impair our ability to conduct any kind of prospective clinical research, said Joshua L Rein, DO, FASN, a nephrologist at Mt. Sinai Hospital in New York City.

Research Highlights Impact of SDOH on Veterans With CKD

October 30th 2020, 4:00pm


A pair of abstracts presented at Kidney Week 2020 underscore the relationship between social determinants of health (SDOH) and chronic kidney disease (CKD) in military populations and the challenges of tracking these factors.

Empagliflozin Cuts Risk of CV, Kidney Events in Heart Failure Regardless of CKD Status

October 24th 2020, 4:15pm


New results from EMPEROR-Reduced presented at Kidney Week 2020.